Tomas Kiselak
10% Owner; Director; Director, 10% Owner · 16 filings · Latest: Sep 9, 2026
Apogee Therapeutics, Inc.
CRESCENT BIOPHARMA, INC.
Damora Therapeutics, Inc.
Galecto, Inc.
Jade Biosciences, Inc.
Korsana Biosciences, Inc.
Oruka Therapeutics, Inc.
Spyre Therapeutics, Inc.
Viridian Therapeutics, Inc.\DE
Zenas BioPharma, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
APGE | Tomas Kiselak | Director | Aug 7, 2026 | Option Exercise | $23.60 | 42,208 | $996.0K | 340,855 | |
CBIO | Tomas Kiselak | Director, 10% Owner | Jul 16, 2026 | Purchase | $14.50 | 853,450 | $12.4M | 3,601,316 | |
ORKA | Tomas Kiselak | Director, 10% Owner | Jul 1, 2026 | Sale | $84.43 | 3,553,410 | $300.0M | 1,131,954 | |
SYRE | Tomas Kiselak | Director | Jun 23, 2026 | Sale | $85.31 | 4,684,781 | $399.7M | 0 | |
ZBIO | Tomas Kiselak | Director | Mar 31, 2026 | Purchase | $20.00 | 150,000 | $3.0M | 2,359,025 | |
GLTO | Tomas Kiselak | 10% Owner | Feb 9, 2026 | Option Exercise | $0.00 | 8,713,000 | — | 2,904,000 | |
APGE | Tomas Kiselak | Director | Jan 22, 2026 | Sale | $76.30 | 1,750,000 | $133.5M | 298,647 |